Rheumatology
Belimumab
$10.00
Universal Activity Number: 407-000-10-029-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 12/01/2010
Expiration date: 12/01/2013
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 12/01/2010
Expiration date: 12/01/2013
Article title:
view more on 407-000-10-029-H01-P
Belimumab: A BLyS-Specific Inhibitor for Systemic Lupus Erythematosus
Certolizumab Pegol
$10.00
Universal Activity Number: 407-000-10-009-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 02/01/2010
Expiration date: 02/01/2013
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 02/01/2010
Expiration date: 02/01/2013
Article title:
view more on 407-000-10-009-H01-P
Certolizumab Pegol: A TNF-α Antagonist for the Treatment of Moderate-to-Severe Crohn's Disease
Golimumab
$10.00
Universal Activity Number: 407-000-10-008-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 01/01/2010
Expiration date: 01/01/2013
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 01/01/2010
Expiration date: 01/01/2013
Article title:
view more on 407-000-10-008-H01-P
Golimumab: A Tumor Necrosis Factor Alpha Inhibitor for the Treatment of Rheumatoid Arthritis
Ustekinumab
$10.00
Universal Activity Number: 407-000-09-018-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 09/01/2009
Expiration date: 09/01/2012
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 09/01/2009
Expiration date: 09/01/2012
Article title:
view more on 407-000-09-018-H01-P
Ustekinumab: Treatment of Adult Moderate-to-Severe Chronic Plaque Psoriasis
Denosumab
$10.00
Universal Activity Number: 407-000-09-016-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 09/01/2009
Expiration date: 09/01/2012
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 09/01/2009
Expiration date: 09/01/2012
Article title:
view more on 407-000-09-016-H01-P
Denosumab in Osteoporosis and Oncology



